Search
for
Sort by
Research 211–240 of 1000+
- Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture
- Sustained release of inhibitor from bionic scaffolds for wound healing and functional regeneration
- Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5
- Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Hair follicle stem cell differentiation is inhibited through cross‐talk between Wnt/β‐catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia
- Antimelanogenic effect of ginsenoside Rg3 through extracellular signal-regulated kinase-mediated inhibition of microphthalmia-associated transcription factor
- High doses of cobalt inhibited hair follicle development in Rex Rabbits
- Abstract 2559: Targeting mTORC1 may provide selectivity for inhibiting proliferation of hair follicle stem/progenitor cells during tumor promotion
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- First drug for severe alopecia recommended by NICE could benefit 14,000 patients
- A machine learning and network framework to discover new indications for small molecules
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- SnapshotDx Quiz: February 2018
- The JAK/STAT signaling pathway: from bench to clinic
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Alopecia areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Tofacitinib for the treatment of lichen planopilaris: A case series
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm